Member Info for Aldebaran

Conversion price is what 46p? Doesn't seem to be

Once ava6000 is given approval presumed fast tracked, it will be for one indication right I.e. for salivary gland cancer?

But then what would stop or the more important question what would encourage the use of off label use? When oncologists see results in sgs without the side effects as well then I would guess off label use would start to spiral?

Can anyone comment or explain please

Ok one more thing.

Modified drugs with precision will mean existing drugs can be put back onto patent and we know what that means.....

Yep

More profit!!

Pmsl. Some absoluge r e t hards on here

Haha so fudster have gone from it being too risky and might not work to the fact it works too well in the blink of an eye. You can't make this up, except they can.

So now we're on the train of thought that it's too good. Ok. Great, all the previous BS about it being too risky can be trashed.

Working too good means people can be dosed in stronger doses = increased profit.

People can be dosed for longer = increased profit.

People can be dosed more frequently = more profit.

People who were previously ineligible for treatment can take it because the safety profile is excellent = more profit

Instead of people dying at the end of treatment, they survive. Maybe to go on and get other cancers = more profit

But yeah it works too well and nobody wants a cure so avacta is finished hahahaha

What a load of BS

90% disease control rate in heavily pre treated patients...

Avacta has a target on its back. Value of a TO has increased or decreased on back of that?

This market is fooked

Short tracker says GSA are still at .078% so no.

They have to close at some point, hopefully get badly burnt in the process.

Think management will pay next CLN in cash, NSADAQ listing on way along with more data read out, AACR in April and sale of DX. There's just not the right risk/reward from this level if you're short in my view.

What, I don't see it? Do you gave proof? No afence

What a word salad. Just say merry Christmas ya melt

6months mate

If FDA have allowed us to start in future other indications at P1b stage because the mechanism is proven then this also could be beneficial for the entire pipeline no?

Would 6103 still require P1a for example? If it does then I would still expect a much shorter p1a and potential to start dosing at higher or more frequent doses I.e. the mechanism is working

So you're saying management might sell out well ok you can say that about literally every investment so no point buying anything. Need to put all your money in a bank where it's safe.

Ridiculous new line of attack.

We're sat on a potential cure for cancer or at least a total revolution in the way it's treat. Management are currently selling dx to raise cash, making plans for NASDAQ listing, creating new patents and pushing ahead with the trials under advice of SAB & FDA. They're trying to drive value on a broken index. Let's see where they are in 6 more months. BP will pay more for certainty as opposed to taking any risk so because they haven't been inundated with offers every other week during p1a should not be construed as lack of interest.

P1b data showing efficacy is where things get real risky for any BP on the sidelines and their hands start to be shown.

If management sell out "cheap", you're still looking at billions

And volatile price of gold lol

Comparing a gold mine to technology set to revolutionise the treatment of cancer is ridiculous. As others have said already there are multiple eyes on Avacta and it's inevitable there will be multiple bids which will drive up the price.

Strewth, a gold mine? Really! Haha

The platform works. Insane really when you think about it.

We all know and yet the SP is where it is. Means the right people don't know. Avacta need to get out on the PR offensive. That's the easy bit. Science is cracked. Amazing

Near complete resolution of multiple pleomorphic metastasis not count as efficacy?

Who has recommended this and why?

On what basis would avacta have agreed to it?

Surely they'd be like, we have our plans and don't have funds for this and presumably the unknown entity has said they'll pay if results are good?

It's the "will be" bit mainly. Too much promise and not enough delivery seen it a thousand times. Price can double for all I care ill wait until there's more certainty. Rather buy with certainty than to try and pick a bottom.

Every jump so far on this stock has been met by a proceeding drop down to make a new low. I'll never buy the bottom but it doesn't matter as the price I do eventually get if I decide to buy will be much lower than most of the long term holders and I'll have much more certainty. It sucks I know but it's reality of how people on the sidelines and not emotionally invested are thinking

Broker targets are laughable. Ignore and no I don't subscribe to this rush to buy and trying to pick a bottom. Would much rather price is higher with volume.

Ideal stocks are ones that are making newer highs.

Like I said boom is not out the water yet, could easily be a dead cat bounce before next leg down.

I'm just saying it's looking better now but needs to confirm by being sustained higher and going higher with more volume. Could easily go the other way right now so no, don't rush to buy

I'm not positive not really but price has started to show some strength. It's in limbo at the minute. Contrary to popular belief I am not and have not talked price down to buy cheaper. I've said ill buy higher happily once it's clear a bottom is in.

All I'm saying is price is starting to look better but not out the woods yet so I continue to stay in the sidelines

Looking much better now. Let's see if it can hold. I'd be tempted to have a punt above £3